SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-041286
Filing Date
2024-05-09
Accepted
2024-05-09 16:05:45
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0204122-10q_inmunebio.htm   iXBRL 10-Q 446913
2 CERTIFICATION ea020412201ex31-1_inmune.htm EX-31.1 10715
3 CERTIFICATION ea020412201ex31-2_inmune.htm EX-31.2 10670
4 CERTIFICATION ea020412201ex32-1_inmune.htm EX-32.1 4267
5 CERTIFICATION ea020412201ex32-2_inmune.htm EX-32.2 4266
  Complete submission text file 0001213900-24-041286.txt   3608713

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inmb-20240331.xsd EX-101.SCH 46375
7 XBRL CALCULATION FILE inmb-20240331_cal.xml EX-101.CAL 30637
8 XBRL DEFINITION FILE inmb-20240331_def.xml EX-101.DEF 184276
9 XBRL LABEL FILE inmb-20240331_lab.xml EX-101.LAB 357122
10 XBRL PRESENTATION FILE inmb-20240331_pre.xml EX-101.PRE 182822
69 EXTRACTED XBRL INSTANCE DOCUMENT ea0204122-10q_inmunebio_htm.xml XML 289502
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 24930448
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)